Join the club for FREE to access the whole archive and other member benefits.

Juvenescence

Developing therapies against different aging related diseases.

Juvenescence is a bio-pharma development company developing therapies focused on allowing people worldwide to live longer, healthier lives. We have raised USD $65M to build an ecosystem and pipeline of assets targeting ageing, age-related disease and regeneration.

Visit website: https://www.juvlabs.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Juvenescence is also referenced in the following:

Company

Developing preventative medicines for age-related disease using ketone bodies

Company

Focused on a novel target linked to one of the fundamental processes of aging

People at Juvenescence

Company Representative

CEO at Juvenescence Life.

Academic

Chief Executive Officer of the Epigenetics Division of Juvenescence Limited

Company Representative

CEO at Juvenescence and chairman of Portage Biotech, Inc.

Juvenescence News

FDA approved LyGenesis' phase 2a trials on liver failure patients

Longevity Technology - 30-Dec-2020

Raised $11M funding which goes into trials and developing functional organs

Read more...

Jim Mellon plans to take his longevity company Juvenescence public

CNBC - 29-Sep-2020

The company with $170 million private funding has invested in various life extension therapies

Read more...

Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed

Read more...

Juvenescence appoints a new CEO for its Epigenetic Division and Souvien Bio Ltd

Juvenescence - 11-Jun-2020

Goal is to develop drugs that target epigenetic mechanisms associated with neurodegeneration

Read more...

Orion College ageing research receives 1 million UK pounds from Jim Mellon

Lifespan.io (LEAF) - 18-May-2020

He believes in the importance of boosting immunoresilience among elderly

Read more...

Master Investor Magazine focuses on longevity in its Autumn edition

Master Investor - 01-Nov-2019

Interesting articles and some useful investment opportunities

Read more...

A mission to change the lives of 1 billion people

Telegraph - 23-Sep-2019

Life extension technology will be expensive, so it'll create inequalities between poor, rich people

Read more...

Today's 50 year-olds may live another 100 years

Forbes - 26-Aug-2019

Good summary of some major investments in life extension companies

Read more...

Aging focused biotechs forms AI based joint venture

FierceBiotech - 14-Aug-2018

Groundbreaking research biotechs performs aging research together for longevity

Read more...

UK biotech company focused on developing anti-ageing therapies

PMLiVE - 12-Jun-2018

LyGenesis seeks to use a patient’s own lymph nodes as bioreactors to grow functioning ectopic organs

Read more...

Interview with Juvenescence author Jim Mellon

Medium - 17-May-2018

Juvenescence Ltd is making investments in the future of rejuvenation and life extension technology

Read more...

Silicon Valley and rich people invest to slow down ageing and live longer

This Is Money - 17-Mar-2018

All the money in the world to fight ageing and death

Read more...

British billionaire gambles on an anti-aging upstart

Endpoints News - 26-Jul-2017

We are at an inflection point for the treatment of aging. We can generate molecules with specifi...

Read more...